{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:50:24Z","timestamp":1794037824602,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192046"],"award-info":[{"award-number":["7192046"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870399"],"award-info":[{"award-number":["81870399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic inflammation is the driving force for the development and progression of NASH. Treatment targeting inflammation is believed to be beneficial. In this study, adoptive transfer of CD4<jats:sup>+<\/jats:sup>T cells converted double negative T cells (cDNT) protects mice from diet-induced liver fat accumulation, lobular inflammation and focal necrosis. cDNT selectively suppress liver-infiltrating Th17 cells and proinflammatory M1 macrophages. IL-10 secreted by M2 macrophages decreases the survival and function of cDNT to protect M2 macrophages from cDNT-mediated lysis. NKG2A, a cell inhibitory molecule, contributes to IL-10 induced apoptosis and dampened suppressive function of cDNT. In conclusion, ex vivo-generated cDNT exert potent protection in diet induced obesity, type 2 diabetes and NASH. The improvement of outcome is due to the inhibition on liver inflammatory cells. This study supports the concept and the feasibility of potentially utilizing this autologous immune cell-based therapy for the treatment of NASH.<\/jats:p>","DOI":"10.1038\/s41467-021-20941-x","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:12:46Z","timestamp":1611832366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis"],"prefix":"10.1038","volume":"12","author":[{"given":"Guangyong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6894-2673","authenticated-orcid":false,"given":"Dan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hufeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongle","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-5173","authenticated-orcid":false,"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"20941_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"20941_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"MM Yeh","year":"2014","unstructured":"Yeh, M. M. & Brunt, E. M. Pathological features of fatty liver disease. Gastroenterology 147, 754\u2013764 (2014).","journal-title":"Gastroenterology"},{"key":"20941_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330\u2013344 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"20941_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka, A. C. et al. Nonalcoholic steatohepatitis: a review. JAMA 323, 1175\u20131183 (2020).","journal-title":"JAMA"},{"key":"20941_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","volume":"150","author":"B Gao","year":"2016","unstructured":"Gao, B. & Tsukamoto, H. Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe? Gastroenterology 150, 1704\u20131709 (2016).","journal-title":"Gastroenterology"},{"key":"20941_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese, M., Cabrera, D., Kalergis, A. M. & Feldstein, A. E. Innate immunity and inflammation in NAFLD\/NASH. Dig. Dis. Sci. 61, 1294\u20131303 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"20941_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI88876","volume":"127","author":"T McLaughlin","year":"2017","unstructured":"McLaughlin, T., Ackerman, S. E., Shen, L. & Engleman, E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J. Clin. Investig. 127, 5\u201313 (2017).","journal-title":"J. Clin. Investig."},{"issue":"3786-3799","key":"20941_CR8","first-page":"e3784","volume":"25","author":"G Sun","year":"2018","unstructured":"Sun, G. et al. OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis. Cell Rep. 25(3786-3799), e3784 (2018).","journal-title":"Cell Rep."},{"key":"20941_CR9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel, O. et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270\u20131283 (2018).","journal-title":"Hepatology"},{"key":"20941_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cei.13159","volume":"193","author":"Y Ilan","year":"2018","unstructured":"Ilan, Y., Shailubhai, K. & Sanyal, A. Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. Clin. Exp. Immunol. 193, 275\u2013283 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"20941_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s001090100238","volume":"79","author":"ZX Zhang","year":"2001","unstructured":"Zhang, Z. X., Young, K. & Zhang, L. CD3(+)CD4(\u2212)CD8(\u2212) alpha beta-TCR+ T cell as immune regulatory cell. J. Mol. Med. 79, 419\u2013427 (2001).","journal-title":"J. Mol. Med."},{"key":"20941_CR12","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","volume":"105","author":"K Fischer","year":"2005","unstructured":"Fischer, K. et al. Isolation and characterization of human antigen-specific TCR alpha beta(+) CD4(\u2212)CD8(\u2212) double-negative regulatory T cells. Blood 105, 2828\u20132835 (2005).","journal-title":"Blood"},{"key":"20941_CR13","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crispin","year":"2008","unstructured":"Crispin, J. C. et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761\u20138766 (2008).","journal-title":"J. Immunol."},{"key":"20941_CR14","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","volume":"183","author":"JC Crispin","year":"2009","unstructured":"Crispin, J. C. & Tsokos, G. C. Human TCR-alpha beta(+) CD4(\u2212) CD8(\u2212) T cells can derive from CD8(+) T Cells and display an inflammatory effector phenotype. J. Immunol. 183, 4675\u20134681 (2009).","journal-title":"J. Immunol."},{"key":"20941_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ni.1741","volume":"10","author":"A Doreau","year":"2009","unstructured":"Doreau, A. et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778\u2013U142 (2009).","journal-title":"Nat. Immunol."},{"key":"20941_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","volume":"51","author":"A Alunno","year":"2014","unstructured":"Alunno, A. et al. CD4(\u2212)CD8(\u2212) T-cells in primary Sjogren\u2019s syndrome: association with the extent of glandular involvement. J. Autoimmun. 51, 38\u201343 (2014).","journal-title":"J. Autoimmun."},{"key":"20941_CR17","doi-asserted-by":"crossref","unstructured":"Hillhouse, E. E., Delisle, J. S. & Lesage, S. Immunoregulatory CD4(\u2212) CD8(\u2212) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Front. Immunol. 4, 6 (2013).","DOI":"10.3389\/fimmu.2013.00006"},{"key":"20941_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jmcb\/mjr043","volume":"4","author":"SC Juvet","year":"2012","unstructured":"Juvet, S. C. & Zhang, L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J. Mol. Cell Biol. 4, 48\u201358 (2012).","journal-title":"J. Mol. Cell Biol."},{"key":"20941_CR19","doi-asserted-by":"crossref","unstructured":"Duncan, B. et al. Double negative (CD3(+)4(\u2212)8(\u2212)) TCR alpha beta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. Plos ONE 5, e11427 (2010).","DOI":"10.1371\/journal.pone.0011427"},{"key":"20941_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2141.2008.07021.x","volume":"141","author":"Z McIver","year":"2008","unstructured":"McIver, Z. et al. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Brit J. Haematol. 141, 170\u2013178 (2008).","journal-title":"Brit J. Haematol."},{"key":"20941_CR21","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1182\/blood-2006-10-050625","volume":"109","author":"D Zhang","year":"2007","unstructured":"Zhang, D. et al. New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109, 4071\u20134079 (2007).","journal-title":"Blood"},{"key":"20941_CR22","doi-asserted-by":"crossref","unstructured":"Zhao, X. et al. A novel differentiation pathway from CD4(+) T cells to CD4(\u2212) T cells for maintaining immune system homeostasis. Cell Death Dis. 7, e2193 (2016).","DOI":"10.1038\/cddis.2016.83"},{"key":"20941_CR23","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00125-011-2179-4","volume":"54","author":"D Zhang","year":"2011","unstructured":"Zhang, D. et al. Adoptive cell therapy using antigen-specific CD4(\u2212)CD8(\u2212) T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice. Diabetologia 54, 2082\u20132092 (2011).","journal-title":"Diabetologia"},{"key":"20941_CR24","doi-asserted-by":"crossref","unstructured":"Liu, T. H. et al. Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD mice. J. Transl. Med. 14, 57 (2016).","DOI":"10.1186\/s12967-016-0815-y"},{"key":"20941_CR25","doi-asserted-by":"crossref","unstructured":"Tian, D. et al. Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma. Nat. Commun. 10, 4246 (2019).","DOI":"10.1038\/s41467-019-12243-0"},{"key":"20941_CR26","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/hep.27284","volume":"60","author":"V Sapp","year":"2014","unstructured":"Sapp, V., Gaffney, L., EauClaire, S. F. & Matthews, R. P. Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition. Hepatology 60, 1581\u20131592 (2014).","journal-title":"Hepatology"},{"key":"20941_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","volume":"770","author":"R Chen","year":"2016","unstructured":"Chen, R. et al. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice. Eur. J. Pharm. 770, 126\u2013133 (2016).","journal-title":"Eur. J. Pharm."},{"key":"20941_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1182\/blood-2010-11-317396","volume":"118","author":"JH Cho","year":"2011","unstructured":"Cho, J. H. et al. Calcineurin-dependent negative regulation of CD94\/NKG2A expression on naive CD8(+) T cells. Blood 118, 116\u2013128 (2011).","journal-title":"Blood"},{"key":"20941_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2012-201511","volume":"72","author":"A Alunno","year":"2013","unstructured":"Alunno, A. et al. IL-17-producing CD4(\u2212)CD8(\u2212) T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren\u2019s syndrome. Ann. Rheum. Dis. 72, 286\u2013292 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"20941_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2017.06.002","volume":"181","author":"D Brandt","year":"2017","unstructured":"Brandt, D., Sergon, M., Abraham, S., Mabert, K. & Hedrich, C. M. T. C. R. CD3(+) CD4(\u2212) CD8(\u2212) effector T cells in psoriasis. Clin. Immunol. 181, 51\u201359 (2017).","journal-title":"Clin. Immunol."},{"key":"20941_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov, K. et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 145\u2013159 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"20941_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2019.00082","volume":"10","author":"MA Van Herck","year":"2019","unstructured":"Van Herck, M. A. et al. The differential roles of T cells in non-alcoholic fatty liver disease and obesity. Front. Immunol. 10, 82 (2019).","journal-title":"Front. Immunol."},{"key":"20941_CR33","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.4049\/jimmunol.172.2.1028","volume":"172","author":"LE Marra","year":"2004","unstructured":"Marra, L. E. et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J. Immunol. 172, 1028\u20131035 (2004).","journal-title":"J. Immunol."},{"key":"20941_CR34","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.cell.2018.11.048","volume":"175","author":"JB Haanen","year":"2018","unstructured":"Haanen, J. B. & Cerundolo, V. NKG2A, a new kid on the immune checkpoint block. Cell 175, 1720\u20131722 (2018).","journal-title":"Cell"},{"key":"20941_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/IR:30:1:029","volume":"30","author":"A Gunturi","year":"2004","unstructured":"Gunturi, A., Berg, R. E. & Forman, J. The role of CD94\/NKG2 in innate and adaptive immunity. Immunol. Res 30, 29\u201334 (2004).","journal-title":"Immunol. Res"},{"key":"20941_CR36","first-page":"1786","volume":"49","author":"D Tian","year":"2019","unstructured":"Tian, D. et al. Double negative T cells mediate Lag3-dependent antigen-specific protection in OVA-induced allergic asthma. Eur. J. Immunol. 49, 1786\u20131786 (2019).","journal-title":"Eur. J. Immunol."},{"key":"20941_CR37","doi-asserted-by":"crossref","unstructured":"Sun, C. et al. High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer. Oncoimmunology 6, e1264562 (2017).","DOI":"10.1080\/2162402X.2016.1264562"},{"key":"20941_CR38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-3083.2007.02034.x","volume":"67","author":"CM Persson","year":"2008","unstructured":"Persson, C. M., Assarsson, E., Vahlne, G., Brodin, P. & Chambers, B. J. Critical role of Qa1(b) in the protection of mature dendritic cells from NK cell-mediated killing. Scand. J. Immunol. 67, 30\u201336 (2008).","journal-title":"Scand. J. Immunol."},{"key":"20941_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2014.02.001","volume":"53","author":"BS Holder","year":"2014","unstructured":"Holder, B. S. et al. Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2. J. Autoimmun. 53, 26\u201332 (2014).","journal-title":"J. Autoimmun."},{"key":"20941_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/mmr.2016.5392","volume":"14","author":"L Gu","year":"2016","unstructured":"Gu, L., Deng, W. S., Sun, X. F., Zhou, H. & Xu, Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17\/Treg cell balance. Mol. Med. Rep. 14, 1153\u20131161 (2016).","journal-title":"Mol. Med. Rep."},{"key":"20941_CR41","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jhep.2013.05.034","volume":"59","author":"YH Oo","year":"2013","unstructured":"Oo, Y. H. & Sakaguchi, S. Regulatory T-cell directed therapies in liver diseases. J. Hepatol. 59, 1127\u20131134 (2013).","journal-title":"J. Hepatol."},{"key":"20941_CR42","doi-asserted-by":"crossref","unstructured":"Strauss, L., Czystowska, M., Szajnik, M., Mandapathil, M. & Whiteside T. L. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. Plos ONE 4, e5994 (2009).","DOI":"10.1371\/journal.pone.0005994"},{"key":"20941_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1681\/ASN.2010040351","volume":"22","author":"G McMahon","year":"2011","unstructured":"McMahon, G., Weir, M. R., Li, X. C. & Mandelbrot, D. A. The evolving role of mTOR inhibition in transplantation tolerance. J. Am. Soc. Nephrol. 22, 408\u2013415 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"20941_CR44","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","volume":"192","author":"H Kato","year":"2014","unstructured":"Kato, H. & Perl, A. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4(+) CD4-CD8-double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J. Immunol. 192, 4134\u20134144 (2014).","journal-title":"J. Immunol."},{"key":"20941_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi, E. & Satija, R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat. Rev. Immunol. 18, 35\u201345 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"20941_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-immunol-042718-041728","volume":"37","author":"K Bassler","year":"2019","unstructured":"Bassler, K., Schulte-Schrepping, J., Warnat-Herresthal, S., Aschenbrenner, A. C. & Schultze, J. L. The myeloid cell compartment-cell by cell. Annu. Rev. Immunol. 37, 269\u2013293 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"20941_CR47","doi-asserted-by":"crossref","unstructured":"Zhao, J. J. et al. Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human. Cell Discov. 6, 22 (2020).","DOI":"10.1038\/s41421-020-0157-z"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-20941-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-20941-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-20941-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T12:00:24Z","timestamp":1697716824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-20941-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20941"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-20941-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S., X.Z., W.S., D.T., H.X., Y.T., K.L., and D.Z. are inventors of a Chinese patent for the method of ex vivo conversion of DNT. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}